Skip to main content
Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
28.36
-4.48 (-13.64%)
At close: Jan 26, 2026

TEVJF Revenue

In the year 2025, Teva Pharmaceutical Industries had annual revenue of $17.26B with 4.32% growth. Teva Pharmaceutical Industries had revenue of $4.71B in the quarter ending December 31, 2025, with 11.40% growth.

Revenue
17.26B
Revenue Growth
+4.32%
P/S Ratio
2.13
Revenue / Employee
539.18K
Employees
32,842
Market Cap
36.69B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202517.26B714.00M4.32%
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Glass House Brands 196.17M
Elite Pharmaceuticals 140.12M
Jushi Holdings 260.43M
Growth Stalk Holdings 583.34K
Sofgen Pharma 423.75M
Radnostix 14.07M
Healthy Extracts 3.59M
MariMed 157.38M
Revenue Rankings

Teva Pharmaceutical Industries News

More News